CC
NAUT icon

Clearline Capital’s Nautilus Biotechnolgy NAUT Stock Holding History

Clearline Capital’s Portfolio NAUT Stock Details NAUT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-144,187
Closed -$411K – 133
2024
Q3 		$411K Sell
144,187
-19,886
-12% -$51.5K 0.02% 132
2024
Q2 		$384K Sell
164,073
-4,911
-3% -$12.8K 0.01% 134
2024
Q1 		$497K Sell
168,984
-65,712
-28% -$186K 0.02% 112
2023
Q4 		$702K Sell
234,696
-30,207
-11% -$86.4K 0.04% 87
2023
Q3 		$837K Hold
264,903
– – 0.07% 107
2023
Q2 		$1.03M Hold
264,903
– – 0.06% 89
2023
Q1 		$734K Hold
264,903
– – 0.11% 82
2022
Q4 		$477K Hold
264,903
– – 0.09% 102
2022
Q3 		$562K Buy
264,903
+2,543
+1% +$6.39K 0.07% 115
2022
Q2 		$706K Buy
262,360
+15,647
+6% +$58.2K 0.09% 103
2022
Q1 		$1.07M Buy
246,713
+18,188
+8% +$74.7K 0.12% 90
2021
Q4 		$1.18M Buy
228,525
+69,395
+44% +$371K 0.13% 88
2021
Q3 		$977K Buy
159,130
+118,018
+287% +$940K 0.09% 102
2021
Q2 		$415K Buy
+41,112
New +$445K 0.06% 120

Other funds holding NAUT

ACM
AH Capital Management Menlo Park, California $1.29B AUM 26.81% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
CM
Cercano Management Bellevue, Washington $2.32B AUM 30.12% 1-Year Est. Return
MVG
Madrona Venture Group Seattle, Washington $22.1M AUM 86.9% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CFM
Comprehensive Financial Management Los Gatos, California $3.01B AUM 2.93% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
ACI
Amazon.com Inc Seattle, Washington $2.63B AUM 20.53% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Clearline Capital's NAUT Position: Q4 2024 in Review

Clearline Capital sold out of Nautilus Biotechnolgy (NAUT) in Q4 2024, closing a stake of 144,187 shares — an estimated $411K sold.

Clearline Capital first reported a position in NAUT in Q2 2021 and held it in 14 quarters. The position peaked at $1.18M in Q4 2021. 88 funds tracked by Wall St. Rank hold NAUT as of Q4 2024.

  • Clearline Capital reported no remaining Nautilus Biotechnolgy position as of Q4 2024 after selling out during the quarter.
  • Clearline Capital sold 144,187 Nautilus Biotechnolgy shares in Q4 2024, an estimated $411K.
  • Clearline Capital first reported a position in Nautilus Biotechnolgy in Q2 2021 and held it in 14 quarters.
  • Clearline Capital's Nautilus Biotechnolgy position peaked at $1.18M in Q4 2021.
  • 88 funds tracked by Wall St. Rank held Nautilus Biotechnolgy as of Q4 2024.

Based on Clearline Capital's 13F filing for Q4 2024, filed 14 Feb 2025.